Corporate Incentives Make Insurers Favor Pushing Brand-Name Drugs Over Cheaper Generics
Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics.